Background Ageing populations are increasing in many countries and bleeding peptic ulcers in patients older than 60 years carry a greater risk of rebleeding and death. This study aimed to identify the risk factors for rebleeding and death in very elderly patients with peptic ulcer bleeding. The efficacy of treatment in preventing recurrent bleeding and death in this group of patients was also studied by means of prospective data collection and analysis. Methods Data relating to 1744 patients treated between September 1985 and January 1994 for peptic ulcer bleeding were collected prospectively and analysed. Patients were stratified by age to one of three groups: group 1 (less than 60 years, n ϭ 833), group 2 (60-79 years, n ϭ 706) and group 3 (80 or more years, n ϭ 205). Results Univariate and multivariate analyses of 21 factors possibly affecting either rebleeding or death identified age greater than 80 years as one of the factors significantly affecting rebleeding and death. In a comparison of groups 1, 2 and 3, the likelihood of rebleeding and death was significantly greater in group 3. Univariate and multivariate analyses for rebleeding and death were performed for each group. The severity of initial bleeding had a marked bearing on subsequent rebleeding rates for all three groups. In group 3, however, large ulcer size and impaired liver function were additional factors which correlated significantly with final outcome. No rebleeding or morbidity occurred when endoscopic treatment was performed early for patients in group 3 but there was a significantly greater risk of further recurrent haemorrhage and treatment-related morbidity when treatment was performed after the onset of rebleeding. Conclusion Patients aged 80 years or greater had the highest risk of rebleeding and death. For patients below 80 years of age, significant factors related to a fatal outcome included co-morbid illness, complications and the need for mechanical ventilation. For patients aged 80 years or older, the significant factors were ulcer size greater than 2 cm and admission with serum bilirubin level above 20 mmol/l. Endoscopic treatment for the very elderly was effective if carried out early.
Many parts of the world are experiencing an increase in ageing populations. In 1988 it was estimated that 10 per cent of a given population were older than 65 years and that by the year 2000 this proportion would increase to 15 per cent 1 . Physiological responses to stress from illness vary with age and elderly patients may not be able to meet increased metabolic demands. Even amongst the elderly, differences exist between a younger cohort and the very old. In this study, a younger cohort aged from 60 to 79 years was defined arbitrarily and the very elderly as being aged 80 years or older; the age limit of 60 years was chosen as this is the official age of retirement in Hong Kong.
Peptic ulcer bleeding consumes substantial resources and requires proficiency in clinical and endoscopic skills for a successful outcome. This is particularly evident in the management of elderly patients as the mortality rate increases from less than 10 per cent for those younger than 60 years to 35 per cent for octogenarians 2 . The high mortality rate in the latter group of patients has not changed over the past 30 years despite improvements in diagnostic techniques and advances in intensive medical care and surgical strategies. A knowledge of risk factors for morbidity and death after peptic ulcer bleeding may help improve treatment outcomes. Previously, the authors have identified age greater than 60 years, previous medical illness, shock on admission, large ulcer size and endoscopic stigmata of recent haemorrhage (ESRH) as significant risk factors for rebleeding and death 3 . However, specific risk factors for the very elderly remain to be established and it is with this aim that these analyses were undertaken.
Patients and methods
Between September 1985 and January 1994, 1744 patients presenting with acute bleeding from peptic ulcer were admitted into a single specialist gastrointestinal surgical unit. Patients were allocated to three groups: group 1 (aged less than 60 years), 2 (aged between 60 and 79 years) and 3 (aged 80 years or greater). All patients admitted were managed in a standardized fashion. Following initial resuscitation, upper gastrointestinal endoscopy was carried out within 24 h of admission. The location and size of any ulcerated areas were documented. Major ESRH were defined as a visible vessel with or without adherent clot, spurting or oozing haemorrhage; minor ESRH were defined as loose clots and black spots in the ulcer base. Patients without major ESRH were managed conservatively and received intravenous H 2 -receptor antagonist therapy following resuscitation. Patients with major ESRH were considered for either endoscopic treatment or immediate operation following resuscitation depending on the presence or absence of shock on presentation, co-morbid illness, rate of bleeding, and endoscopic findings including ulcer site and size. Surgical intervention was favoured in patients with shock on presentation in whom bleeding was brisk, particularly when comorbid illness was absent, ulcer size was very large and/or access for endoscopic therapy was considered difficult. Adrenaline (1:10 000) injection and/or thermal coagulation using a heater probe were employed for endoscopic therapy.
Patients were monitored serially for persistent bleeding or rebleeding. Rebleeding was defined as fresh haematemesis or Paper accepted 22 September 1997 melaena, fall in systolic blood presssure (to below 100 mmHg or by 50 mmHg) or fall of haemoglobin level of 2 g/dl or more after correction of anaemia 3 . Patients with rebleeding after conservative or endoscopic treatment underwent operation. The emergency surgery group, therefore, comprises patients who underwent immediate operation on first presentation without initial conservative treatment and those in whom emergency operation was performed to control rebleeding.
Clinical, laboratory, endoscopic, treatment and outcome data including postoperative morbidity were collected prospectively and entered into a computer database for statistical analysis. Previous medical illness was documented as being present when the patient had a history of ischaemic heart disease, hypertension, cerebrovascular accident, diabetes mellitus, chronic obstructive airways disease, tuberculosis, chronic renal failure, cirrhosis or malignant disease. Pretreatment transfusion was defined as any transfusion before therapeutic endoscopy and/or surgery.
Risk factors for rebleeding and death were studied first for the entire group of 1744 patients and then for groups 1, 2 and 3 separately. These included 16 patient factors and five ulcer factors. The number of units of blood transfused before institution of treatment and the total number of units of blood transfusion were also included in the analysis of risk factors for rebleeding and death. The patients in group 3 were evaluated in detail with particular emphasis on the pathology of ulcers and treatment outcome.
Statistical analysis
Data were analysed using the computer software SPSS for Windows release 6.0 (SPSS, Chicago, Illinois, USA). Comparisons between groups were made using the Mann-Whitney U test, Fisher's exact test or 2 test as applicable. Multivariate analysis of treatment outcome was performed using a stepwise logistic regression model. Statistical significance was taken at P Յ 0·05.
Results
Of 1744 patients, endoscopic treatment was performed for 301 (17·3 per cent) and emergency surgery was undertaken in 132 (7·6 per cent). One hundred and seventeen patients (6·7 per cent) underwent early elective operation after haemodynamic stabilization. Rebleeding occurred in 276 patients (15·8 per cent) and 68 (3·9 per cent) died, 42 of whom had rebled. Rebleeding after endoscopic treatment, emergency surgery and elective surgery was encountered in 28 patients (9·3 per cent), nine (6·8 per cent) and nine (7·7 per cent) respectively. Seventy-eight patients developed complications after endoscopic or surgical treatment. Mechanical ventilation was required in 40 and parenteral nutrition in 21 patients. Twenty-six patients died after complications; the occurrence of complications significantly increased mortality rate (P Ͻ 0·0001).
Eight hundred and thirty-three patients (47·8 per cent), 706 (40·5 per cent) and 205 (11·8 per cent) were stratified to groups 1, 2 and 3 respectively. The male to female ratio and the location of peptic ulceration in patients in group 3 were significantly different form those in groups 1 and 2 ( Table 1) . Moreover, those in group 3 had significantly greater rebleeding and mortality rates, and a higher proportion died after rebleeding.
Univariate analyses of risk factors for rebleeding and death performed for all 1744 patients showed that significantly more patients rebled and died when ulceration was confined to the stomach. Of the 597 patients with gastric ulcer, 142 (23·8 per cent) and 38 (6·4 per cent) rebled and died respectively. The corresponding figures for the 905 patients with duodenal ulcer were 107 (11·8 per cent) and 24 (2·7 per cent). Moreover, rebleeding and death were significantly related to ulcer size (P Ͻ 0·02) and the presence of ESRH (P Ͻ 0·01). The mean(s.d.) ulcer size in patients who rebled was 1·8(1·7) cm and 2·5(1·9) cm in patients who succumbed. However, the number of ulcers was found not to have a significant effect on the likelihood of rebleeding or death.
The clinical risk factors for rebleeding and death are shown in Table 2 . A history of ulcerogenic drug ingestion was not significantly related to rebleeding or death. Significant variables were identified and then further studied by multivariate analysis using a stepwise logistic regression model. Age 80 years or greater was identified as one of the factors affecting rebleeding ( Table 3) . Separate evaluation of groups 1, 2 and 3 by univariate and multivariate analyses identified similar factors significantly affecting rebleeding rates ( Table 4) . Risk factors for death amongst the very old differed, however, from those evident in younger patients. An increased risk of death was noted in patients aged less than 60 years with comorbid conditions who developed a complication, particularly when mechanical ventilatory support was required. In group 3 the relative risk of death increased to 6·2 when pretreatment transfusion exceeded 4 units of blood, to 7·3 when ulcer size was greater than 2 cm and to 4·2 when bilirubin level on admission exceeded 20 mmol/l ( Table 5 ).
The nature of ulceration in group 3 was studied in detail ( Table 6 ). The size and number of ulcers as well as the rebleeding and mortality rates were not statistically different with regard to the ulcer location. Of patients with ESRH, 12 had recurrent bleeding after treatment, six after endoscopic therapy, three after emergency operation and three following early elective surgery. Thirteen patients died after treatment but there was no correlation between death and the type of treatment received; ten deaths were associated with treatment-related complications and only three were related to bleeding. It is particularly noteworthy that neither rebleeding nor death occurred if endoscopic therapy was performed early for 'at risk' patients at presentation. However, 11 of 52 patients (21 per cent) who rebled following admission experienced repeated bleeding after surgery (P Ͻ 0·001). Three continued to bleed and died. Patients with rebleeding were also more susceptible to the development of complications after treatment. The outcome was fatal in ten of 14 patients who developed complications, 11 of whom had experienced an episode of rebleeding (P ϭ 0·002).
Discussion
Acute bleeding from peptic ulcer will usually stop spontaneously, irrespective of age, and there is no 
Values in parentheses are 95 per cent confidence intervals. BUN, blood urea nitrogen (normal range 2·5-6·4 mmol/l); ESRH, endoscopic stigmata of recent haemorrhage. Stepwise logistic regression evidence that the elderly have more severe bleeding at presentation than younger patients 4 . Massive bleeding in the elderly is, however, associated with a mortality rate of 50-70 per cent and conventional management has in the past, therefore, emphasized early operation to prevent rebleeding and death 5, 6 . The overall mortality rate for emergency surgery in the very old has fallen from 20 to 10 per cent over the past two decades, but for urgent gastroduodenal surgical intervention, this remains at 25-35 per cent, significantly higher than in younger individuals 1, 7, 8 . In a previous report 9 , immediate operation to control non-variceal gastrointestinal haemorrhage in patients aged over 50 years was not shown to confer any advantage over initial conservative management, and carried a mortality rate of 11·4 per cent which was not significantly different from the figure of 7·9 per cent documented in the conservative treatment group. This high mortality rate has been ascribed to co-morbid conditions, which are present in about 50 per cent of the very old 10 , and was 27·3 per cent for patients with associated medical illness but only 6·7 per cent for those without such an association 9 . With the development of successful endoscopic haemostatic techniques, more patients are being so treated in the hope that surgery and thus postoperative morbidity may be avoided. Although an initial haemostatic rate of over 90 per cent can be achieved, 10-19 per cent of patients will rebleed after treatment and many of these patients subsequently require operation 11, 12 .
In the present study, risk factors for rebleeding and death in the whole group of 1744 patients were in keeping with previously reported experience 3 . Rebleeding in this series was associated with a tenfold increase in mortality rate. When each of the selected age groups was studied separately, rebleeding was related to the severity of initial haemorrhage which was reflected by the number of units of blood transfused either before treatment or in total. Risk factors for death varied between the three groups. Patients aged less than 60 years were more likely to succumb if there was concomitant medical illness and if mechanical ventilatory support was required. The risk of death if complications arose after treatment was 96 times greater than when recovery was uneventful. Careful monitoring of patients at risk is required, with measures to prevent complications. Although hypotension should obviously be corrected to improve tissue perfusion, fluid overload, with the risk of pulmonary oedema, must be avoided.
Although treatment-related complications also constituted a risk factor for death in patients aged 60-79 years, the relative risk of death was only 17·9. The magnitude of initial bleeding also determined the final outcome in this group of patients. Severe bleeding with tachycardia and a need for continuous transfusion requires early intervention by endoscopic means or immediate operation.
In patients older than 80 years, the risk of death was increased in those with features of severe bleeding at presentation. Large ulcer size and impaired liver function were additional risk factors for death. Patients with such risk factors should be considered for initial endoscopic treatment and it is evident that gastric ulceration is associated with an increased need for intervention which is consistent with the observation of an increased risk of rebleeding when ulceration occurs in the stomach. Nevertheless, the time for complete healing of a large ulcer may be protracted, with the possibility of a rebleed occurring before ulceration is healed. Early operation, with excision of the ulcer if possible, is an option after bleeding has been controlled endoscopically and the condition of the patient has improved. A patient with impaired liver function needs to be carefully assessed as to the advisability of early intervention to prevent ongoing bleeding and minimize the potential effects of massive transfusion in the presence of already compromised liver reserve. Such patients may tolerate operation poorly and every effort must be made to achieve successful haemostasis at therapeutic endoscopy.
When intervention is deemed necessary therapeutic endoscopy is the treatment of choice for very elderly patients and must be carried out before rebleeding occurs. There was no further bleeding or death if such treatment was given early but 21 per cent of patients who rebled developed further bleeding even after treatment for the rebleeding episode. The latter group of patients are also more susceptible to treatment-related complications and, as a result, a majority succumb.
